These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 849874

  • 41. Complement and leukocyte independent proteinuria and eicosanoid synthesis in rat membranous nephropathy.
    Rahman MA, Liu CN, Dunn MJ, Emancipator SN.
    Lab Invest; 1988 Oct; 59(4):477-83. PubMed ID: 3050273
    [Abstract] [Full Text] [Related]

  • 42. A new role of the complement system: C3 provides protection in a mouse model of lung infection with intracellular Chlamydia psittaci.
    Bode J, Dutow P, Sommer K, Janik K, Glage S, Tümmler B, Munder A, Laudeley R, Sachse KW, Klos A.
    PLoS One; 2012 Oct; 7(11):e50327. PubMed ID: 23189195
    [Abstract] [Full Text] [Related]

  • 43. [Levels of complement components in plasma of onco-hematologic patients with defective hemopoiesis].
    Rybakova LP, Tiagotin IV, Ganapiev AA, Moiseev SI, Ushakova EA, Abdulkadyrov KM, Ishchenko AM.
    Vopr Onkol; 1996 Oct; 42(2):63-7. PubMed ID: 8815636
    [Abstract] [Full Text] [Related]

  • 44. Pathophysiology of the interaction between complement and non-complement proteases.
    Nydegger UE, Suter S.
    Adv Exp Med Biol; 1984 Oct; 167():227-34. PubMed ID: 6369909
    [No Abstract] [Full Text] [Related]

  • 45. Mechanism of action of blocking immunoglobulin G for Neisseria gonorrhoeae.
    Joiner KA, Scales R, Warren KA, Frank MM, Rice PA.
    J Clin Invest; 1985 Nov; 76(5):1765-72. PubMed ID: 3932472
    [Abstract] [Full Text] [Related]

  • 46. Further studies of the adjuvant properties of homologous IgG split products: mode of action of F(ab')2 and related fragments.
    Kulberg AJ, Bartova LM, Evnin DN.
    Immunology; 1978 Feb; 34(2):199-206. PubMed ID: 342398
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Babesia rodhaini: requirement of complement for penetration of human erythrocytes.
    Chapman WE, Ward PA.
    Science; 1977 Apr 01; 196(4285):67-70. PubMed ID: 841340
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Composition of immune deposits present in glomeruli of NZB/W F1 mice.
    Sugisaki T, Takase S.
    Clin Immunol Immunopathol; 1991 Dec 01; 61(3):296-308. PubMed ID: 1934620
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. The covalent interaction of C3 with IgG immune complexes.
    Vivanco F, Muñoz E, Vidarte L, Pastor C.
    Mol Immunol; 1999 Dec 01; 36(13-14):843-52. PubMed ID: 10698338
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Complement activation in patients with renal failure as detected through the quantitation of fragments of the complement proteins C3, C5, and factor B.
    Oppermann M, Haubitz M, Quentin E, Götze O.
    Klin Wochenschr; 1988 Sep 15; 66(18):857-64. PubMed ID: 3184764
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. The formation of insoluble immune complexes between ovalbumin and anti-ovalbumin IgG occurs in at least two distinct phases dependent on reactant concentration and ionic strength.
    Gorgani NN, Easterbrook-Smith SB, Altin JG.
    Biochim Biophys Acta; 1996 Oct 07; 1317(1):45-54. PubMed ID: 8876626
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.